(Q45033939)

8 December 2017

C-type natriuretic peptide ameliorates monocrotaline-induced pulmonary hypertension in rats (English)

1 reference

8 December 2017

pulmonary hypertension

1 reference

Takefumi Itoh

1

1 reference

8 December 2017

Noritoshi Nagaya

2

1 reference

8 December 2017

Shinsuke Murakami

3

1 reference

8 December 2017

Takafumi Fujii

4

1 reference

8 December 2017

Takashi Iwase

5

1 reference

8 December 2017

Hatsue Ishibashi-Ueda

6

1 reference

8 December 2017

Chikao Yutani

7

1 reference

8 December 2017

Masakazu Yamagishi

8

1 reference

8 December 2017

Hiroshi Kimura

9

1 reference

8 December 2017

Kenji Kangawa

10

1 reference

8 December 2017

language of work or name

English

0 references

publication date

27 August 2004

1 reference

American Journal of Respiratory and Critical Care Medicine

8 December 2017

1 reference

8 December 2017

170

1 reference

8 December 2017

1204-1211

1 reference

8 December 2017

11

1 reference

Primary pulmonary hypertension. A national prospective study

8 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Pulmonary hypertension and inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Vascular natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Effects of intravenously administered C-type natriuretic peptide in humans: comparison with atrial natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

C-type natriuretic peptide induces redifferentiation of vascular smooth muscle cells with accelerated reendothelialization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Accelerated reendothelialization with suppressed thrombogenic property and neointimal hyperplasia of rabbit jugular vein grafts by adenovirus-mediated gene transfer of C-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Significance and therapeutic potential of the natriuretic peptides/cGMP/cGMP-dependent protein kinase pathway in vascular regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Gene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Pulmonary capillary density in rats given monocrotaline. A cast corrosion study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Protective role of angiopoietin-1 in experimental pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Distribution of plasminogen activator inhibitor (PAI-1) in tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

Natriuretic factors and nitric oxide suppress plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

CX3C Chemokine Fractalkine in Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200404-455OC

10.1164/RCCM.200404-455OC

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference